Reports for HIKMA CANADA LIMITED
Company Name
HIKMA CANADA LIMITED
Totals |
||
Shortage reports |
82 |
|
| Actual shortage: | 12 (15%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 1 (1%) | |
| Resolved: | 69 (84%) | |
Discontinuation Reports |
4 |
|
| To be discontinued: | 3 (75%) | |
| Discontinued: | 1 (25%) | |
| Reversed: | 0 (0%) | |
Late reports |
16 (19%) |
|
Overdue reports |
9 (60%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACETYLCYSTEINE SOLUTION USP | 200MG | SOLUTION | Resolved | 2022-10-06 | 2023-06-02 | 171228 |
| EPINEPHRINE INJECTION USP | 1MG | SOLUTION | Resolved | 2022-06-20 | 2022-08-16 | 163112 |
| LIDOCAINE HYDROCHLORIDE INJECTION USP | 10MG | SOLUTION | Resolved | 2022-04-14 | 2022-09-08 | 158884 |
| LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION USP | 0.01MG 20MG | SOLUTION | Resolved | 2022-04-14 | 2023-02-21 | 158881 |
| DIMENHYDRINATE INJECTION USP | 50MG | SOLUTION | Resolved | 2022-04-14 | 2022-06-07 | 158877 |
| EPINEPHRINE INJECTION USP | 1MG | SOLUTION | Resolved | 2022-03-30 | 2022-04-28 | 157571 |
| SUCCINYLCHOLINE CHLORIDE INJECTION USP | 20MG | SOLUTION | Resolved | 2022-02-25 | 2022-04-27 | 155681 |
| STERILE WATER FOR INJECTION USP | 100% | SOLUTION | Resolved | 2022-02-04 | 2022-08-16 | 154254 |
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION | 0.5G 4G | POWDER FOR SOLUTION | Resolved | 2022-01-28 | 2022-07-22 | 153842 |
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION | 3G 0.375G | POWDER FOR SOLUTION | Resolved | 2022-01-28 | 2022-07-22 | 153839 |
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION | 0.25G 2G | POWDER FOR SOLUTION | Resolved | 2022-01-28 | 2022-07-22 | 153835 |
| STERILE WATER FOR INJECTION USP | 100% | SOLUTION | Resolved | 2021-07-20 | 2022-01-25 | 142812 |
| 0.9% SODIUM CHLORIDE INJECTION USP | 9MG | SOLUTION | Resolved | 2021-07-20 | 2023-01-20 | 142809 |
| LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION USP | 0.01MG 20MG | SOLUTION | Actual shortage | 2021-05-14 | 2021-05-15 | 139438 |
| ERGONOVINE MALEATE INJECTION USP | 0.25MG | SOLUTION | Resolved | 2021-05-14 | 2021-09-04 | 139434 |
| 0.9% SODIUM CHLORIDE INJECTION USP | 9MG | SOLUTION | Resolved | 2021-01-29 | 2021-04-15 | 132779 |
| PHENYTOIN SODIUM INJECTION USP | 50MG | SOLUTION | Resolved | 2020-12-17 | 2021-01-20 | 130361 |
| PHENYTOIN SODIUM INJECTION USP | 50MG | SOLUTION | Resolved | 2020-12-17 | 2020-12-25 | 130358 |
| GENTAMICIN INJECTION USP | 10MG | SOLUTION | Resolved | 2020-11-09 | 2020-12-03 | 128174 |
| CEFUROXIME FOR INJECTION, USP | 750MG | POWDER FOR SOLUTION | Actual shortage | 2020-08-13 | 2020-10-31 | 122228 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| LIDOCAINE HYDROCHLORIDE INJECTION USP | 10MG | SOLUTION | Discontinued | 2024-04-19 | 2024-04-22 | 225805 |
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION | 0.5G 4G | POWDER FOR SOLUTION | To be discontinued | 2022-07-21 | 2022-07-21 | 165196 |
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | To be discontinued | 2022-07-21 | 2022-07-21 | 165193 |
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION | 2G 0.25G | POWDER FOR SOLUTION | To be discontinued | 2022-07-21 | 2022-07-21 | 165188 |
Showing 1 to 4 of 4